References
Bhalla AK, Amento EP, Krane SM (1986) Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol 98: 311–322
Bittiner B, Bleehen SS, Macneil S (1991) 1α,25(OH)2 vitamin D3 increases intracellular calcium in human keratinocytes. Br J Dermatol 124: 230–235.
Breathnach SM, Katz SI (1985) Cell-mediated immunity in cutaneous disease. Hum Pathol 17: 161–167
Elmets CA, Bergstresser PR, Tigelaar RE, Wood PJ, Streilein JW (1983) Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 158: 781–794
Guo ZP, Okamoto H, Imamura S (1991) The optimal conditions of adenosine nucleotide phosphatase staining for Langerhans cell of human, guinea pig and mouse. Acta Dermatol (Kyoto) 86: 215–218
Hashimoto K, Matsumoto K, Higashiyama M, Nishida Y, Yoshikawa K (1990) Growth-inhibitory effects of 1,25-dihydroxyvitamin D3 on normal and psoriatic keratinocytes. Br J Dermatol 123: 93–98
Heufler C, Koch F, Schuler G (1988) Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167: 700–705
Holick MF (1989) Will 1,25-hydroxyvitamin D3, MC 903, and their analogues herald a new pharmacologic era for the treatment of psoriasis? Arch Dermatol 125: 1692–1697
Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T (1983) Regulation of terminal differentiation of cultured mouse epidermal cells by l,25-dihydroxyvitamin D3. Endocrinology 113: 1950–1957
Kato T, Rokugo M, Terui T, Tagami H (1986) Successful treatment of psoriasis with topical application of active vitamin D3 analogue, 1α,24-dihydroxycholecalciferol. Br J Dermatol 115: 431–433
Kim TA, Golden P, Ullrich SE, Kripke ML (1990) Immunosuppression by factors released from UV-irradiated epidermal cells: selective effects on the generation of contact and delayed hypersensitivity after exposure to UVA or UVB radiation. J Invest Dermatol 94: 26–32
Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1α, 1,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74: 657–661
Matsumoto K, Hashimoto K, Kiyoki M, Yamamoto M, Yoshikawa K (1990) Effect of l,24R-dihydroxyvitamin D3 on the growth of human keratinocytes. J Dermatol (Japan) 17: 97–103
Morimoto S, Kumahara Y (1985) A patient with psoriasis cured by 1α-hydroxyvitamin D3. Med J Osaka Univ 35: 51–54
Morimoto S, Yoshikawa K (1989) Psoriasis and vit D3. Arch Dermatol 125: 231–234.
Morimoto S, Yoshikawa K, Kozuka T, Kitano Y, Imanaka S, Fukuo K, Koh E, Kumahara Y (1986) An open study of vitamin D3 treatment in psoriasis vulgaris. Br J Dermatol 115: 421–429
Smith EL, Walworth ND, Holick MF (1986) Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86: 709–714
Smith EL, Pincus SH, Donovan L, Holick MF (1988) A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 19: 516–528
Staberg B, Roed-Petersen J, Meene T (1989) Efficacy of topical treatment in psoriasis with MC 903, a new Vitamin D analogue. Acta Derm Venereol (Stockh.) 69: 147–150
Stingl G, Katz SI, Clement L, Geen I, Shevach EM (1978) Immunologic functions of Ia-bearing epidermal Langerhans cells. J Immunol 121: 2005–2013
Stumpf WE, Sar M, Reid FA, Tanaka Y, DeLuca HF (1979) Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188–1190
Tsoukas CD, Provvedine DM, Manolagas SC (1984) 1,25-dihydroxyvitamin D3, a novel immunoregulatory hormone. Science 224: 1438–1440
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guo, Z., Okamoto, H. & Imamura, S. The effect of 1,25(OH)2-vitamin D3 on Langerhans cells and contact hypersensitivity in mice. Arch Dermatol Res 284, 368–370 (1992). https://doi.org/10.1007/BF00372042
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00372042